The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read more
HotSpot Therapeutics recently announced FDA clearance of our Investigational New Drug (IND) application for HST-1011, our small molecule allosteric inhibitor...
Read more
White Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system...
Read more
It is in moments like this that we are reminded of the collective power of good to overcome the disenfranchised…
Read more
Today marks an important point in our journey to patients as HotSpot Therapeutics announces its $100MM Series C financing. This infusion of…
Read more
Returning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace
Read more
Today marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a...
Read more
The conventional approach to drug discovery shines a light on specific target proteins, using an arsenal of biochemical and virtual...
Read more
The predictions around the impact of artificial intelligence (AI) have been broad reaching but it’s clear that not everyone is...
Read more
This is an exciting time for small molecule drug discovery and soon for patients, who have been underserved by current...
Read more